Patent ID: 8524752

Claim:
A method for the treatment of psoriasis comprising administering to a patient in need thereof an effective amount of a pharmaceutical composition containing at least one thiazolidin-4-one derivative of the General Formula (II) wherein: R 14 represents lower alkyl; lower alkenyl; cycloalkyl; 5,6,7,8-tetrahydronaphth-1-yl; 5,6,7,8-tetrahydronaphth-2-yl; a phenyl group; or a phenyl group mono-, di- or tri-substituted independently with lower alkyl, halogen, lower alkoxy, or —CF 3 ; R 15 represents lower alkyl; allyl; cyclopropyl; cyclobutyl; cyclopentyl; or mono- or di-lower alkylamino; R 16 represents hydrogen; hydroxy; lower alkoxy; lower alkyl; or halogen; R 17 represents hydrogen, lower alkyl, or hydroxymethyl; R 18 , R 19 , R 21 and R 22 each represents independently hydrogen or methyl; R 20 represents hydrogen or lower alkyl; and in case m represents the integer 1, R 20 in addition represents lower alkoxy, hydroxy, —NH 2 , —NHR 5 or —NR 5 R 6 , wherein R 5 and R 6 each represents independently lower alkyl; R 23 represents hydrogen; lower alkyl; hydroxycarbonyl-lower alkyl; 1-glyceryl; or 2-glyceryl; m represents the integer 0 or 1, in free or pharmaceutically acceptable salt form.